HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ethylenethiourea: a review of teratogenicity and distribution studies and an assessment of reproduction risk.

Abstract
Ethylenethiourea (ETU) is a specific neuroteratogen that induces communicating hydrocephalus ex vacuo at oral doses far lower than those that cause any observable toxic sign or 50% death (LD50) in the rat dam. The teratogenic activity appears to be related to ETU itself and not to its metabolites. It is dependent upon the presence of an imidazolidine ring with a specific molecular location of sulfur atom. It is unlikely that ETU-induced alterations in thyroid function or thyroxine levels in the maternal rat are involved in teratogenic activity. The initial target following maternal dosing with ETU is the primitive neuroblast that undergoes necrosis, but the subsequent changes leading to the development of hydrocephalus are not clear. Teratogenicity studies in hamsters, mice, guinea pigs, rabbits, and rats revealed that ETU either required extremely high doses to produce malformations or was ineffective. The results of various distribution studies are summarized. Further, investigations dealing with exposure to ETU in the general population and in exposed workers in the rubber industry as well as those involved in the manufacture and spraying of fungicides are discussed briefly with reference to reducing the exposure levels.
AuthorsK S Khera
JournalCritical reviews in toxicology (Crit Rev Toxicol) Vol. 18 Issue 2 Pg. 129-39 ( 1987) ISSN: 1040-8444 [Print] England
PMID3311641 (Publication Type: Journal Article, Review)
Chemical References
  • Imidazoles
  • Teratogens
  • Ethylenethiourea
Topics
  • Animals
  • Ethylenethiourea (toxicity)
  • Humans
  • Imidazoles (toxicity)
  • Risk Factors
  • Teratogens

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: